CRISERNA is a UK-based genome editing consultancy built on the belief that scientific precision must go hand in hand with ethical integrity.
We support researchers, biotech startups, and translational labs through:
🔬 AI-assisted in silico CRISPR design
🧬 Ethical and regulatory genome editing strategy
🧫 Bespoke applications in oncology, rare disease, and agriculture
Whether you’re developing a gene therapy, optimizing an sgRNA library, or building a spatial omics pipeline — we help you design smarter, safer, and more scalable genome editing solutions.
CRISERNA is led by researchers and bioethicists with hands-on experience in target discovery, 3D organoid models, and computational biology.
Our mission:
To make genome editing responsible, real-world ready, and radically innovative.
🌐 www.criserna.com
Company Details
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.criserna.com
- Keywords
- CRISPR strategy, in silico modelling, genome editing, AI in biology, target discovery, ethical innovation, oncology, agriculture.
- HQ
- London
Criserna Questions
Criserna's website is http://www.criserna.com
Criserna's LinkedIn profile is https://uk.linkedin.com/company/criserna
Criserna's industry is
Biotechnology Research
Criserna's top competitors are
Episome Biotechnologies,
Tenzing Partners,
Tttech Auto,
Allanta Vzw,
Plantechology,
Biggplus,
Biomedica Gmbh,
Evox Therapeutics Ltd,
Palgae,
Oncotrust.
Criserna's categories are Biotechnology Research
Criserna's founding year is 2025
